Ivan V. Chernikov

Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group

Natalya S. Petrova, Ivan V. Chernikov, Mariya I. Meschaninova et al. · Nucleic Acids Research · 2011 · 93 citations · Full text

Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene

Ivan V. Chernikov, Daniil V. Gladkikh, Mariya I. Meschaninova et al. · Molecular Therapy — Nucleic Acids · 2017 · 82 citations · Full text

Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells

Maxim S. Kupryushkin, Anton V. Filatov, Olga Patutina et al. · Molecular Therapy — Nucleic Acids · 2021 · 32 citations · Full text

Antisense Oligonucleotide Gapmers, Drug Resistance Analysis, Phosphoryl Guanidine Groups +9

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

Oleg V. Markov, Ivan V. Chernikov, Daniil V. Gladkikh et al. · Science Advances · 2018 · 26 citations · Full text

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics

Oleg V. Markov, Anton V. Filatov, Maxim S. Kupryushkin et al. · Molecules · 2020 · 20 citations · Full text